SEC Form 4 · accession 0001209191-19-006641
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
Feb 1, 2019
Accepted (ET)
Feb 1, 2019 · 9:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSU)F1,F2 | — | Feb 1, 2019 | A | 27,260 | A | — | — | Ordinary Shares | 27,260 | 27,260 | I |
Explanation of responses
- F1Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- F2The RSU's vest 1/3rd annually on each anniversary of February 1, 2019.